CIBC Private Wealth Group LLC increased its holdings in Centene Co. (NYSE:CNC – Free Report) by 45.1% during the fourth quarter, Holdings Channel.com reports. The firm owned 9,242 shares of the company’s stock after acquiring an additional 2,871 shares during the quarter. CIBC Private Wealth Group LLC’s holdings in Centene were worth $584,000 at the end of the most recent quarter.
Several other hedge funds have also added to or reduced their stakes in the business. MV Capital Management Inc. lifted its stake in shares of Centene by 0.6% in the 4th quarter. MV Capital Management Inc. now owns 31,889 shares of the company’s stock valued at $1,932,000 after acquiring an additional 202 shares during the last quarter. Allianz SE bought a new stake in Centene in the fourth quarter valued at approximately $190,000. Cornercap Investment Counsel Inc. boosted its stake in shares of Centene by 40.6% during the fourth quarter. Cornercap Investment Counsel Inc. now owns 26,907 shares of the company’s stock valued at $1,630,000 after purchasing an additional 7,769 shares during the period. Allstate Corp bought a new position in shares of Centene in the fourth quarter worth approximately $951,000. Finally, Brown Brothers Harriman & Co. bought a new stake in Centene during the 4th quarter valued at $47,000. 93.63% of the stock is owned by institutional investors.
Centene Price Performance
CNC stock opened at $62.13 on Friday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.10 and a current ratio of 1.11. The firm has a market capitalization of $30.82 billion, a price-to-earnings ratio of 9.96, a PEG ratio of 0.80 and a beta of 0.40. The firm has a 50 day moving average price of $59.72 and a 200-day moving average price of $62.35. Centene Co. has a 52-week low of $55.03 and a 52-week high of $80.59.
Analyst Upgrades and Downgrades
A number of research firms have issued reports on CNC. Truist Financial decreased their price objective on shares of Centene from $89.00 to $84.00 and set a “buy” rating on the stock in a research report on Friday, December 13th. UBS Group upgraded Centene from a “neutral” rating to a “buy” rating and boosted their price target for the company from $79.00 to $80.00 in a report on Friday, December 13th. Argus lowered Centene from a “buy” rating to a “hold” rating in a research report on Thursday, February 6th. Jefferies Financial Group downgraded Centene from a “hold” rating to an “underperform” rating and decreased their target price for the company from $68.00 to $52.00 in a report on Tuesday, December 10th. Finally, Oppenheimer cut their price target on shares of Centene from $95.00 to $85.00 and set an “outperform” rating on the stock in a report on Friday, December 13th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and ten have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $79.92.
Check Out Our Latest Analysis on CNC
Centene Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Further Reading
- Five stocks we like better than Centene
- The Basics of Support and Resistance
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Golden Cross Stocks: Pattern, Examples and Charts
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.